World's First Pig Kidney Transplant Recipient in Massachusetts Dies at Age 62

https://icaro.icaromediagroup.com/system/images/photos/16210240/original/open-uri20240512-17-d1923t?1715478261
ICARO Media Group
Politics
12/05/2024 01h42

In a tragic turn of events, Rick Slayman, the Massachusetts man who made medical history as the first person to receive a pig kidney transplant, has passed away at the age of 62. The groundbreaking procedure took place at Massachusetts General Hospital on March 21, but sadly, Slayman's life was cut short just two months later.

Following the transplant, Slayman, a resident of Weymouth, was discharged from the hospital after two weeks and sent home to continue his recovery. The kidney he received underwent genetic alteration to remove pig genes and incorporate human ones, enhancing its capabilities for transplantation.

Massachusetts General Hospital announced the news of Slayman's passing on Saturday, emphasizing that there is no indication that his death was in any way related to the transplant. The hospital's transplant team expressed deep sadness over the loss and recognized Slayman as an emblem of hope for countless transplant patients worldwide.

Slayman had been living with hypertension and Type 2 diabetes for several years. In 2018, he underwent a human kidney transplant, which ultimately began to fail after five years, leading him to pursue the pioneering pig kidney transplant.

In a heartfelt statement, Slayman's family remembered him as an inspiration to many around the globe. They described him as a kind-hearted man with a quick-witted sense of humor, devoted to his family, friends, and co-workers. Slayman's family also highlighted his determination to provide hope for those waiting desperately for a transplant, noting that he achieved this goal and left behind a legacy that will continue to inspire patients, researchers, and healthcare professionals.

Amid their grief, the family requested privacy during this difficult time. Slayman's passing serves as a reminder of the uncertainties that can accompany groundbreaking medical procedures, despite the advancements they offer in the field of xenotransplantation.

As the medical community mourns the loss of a brave individual who contributed to scientific progress, the memory of Rick Slayman's resilience and selflessness will undoubtedly endure as a testament to the power of hope and the quest for a better future in organ transplantation.

The views expressed in this article do not reflect the opinion of ICARO, or any of its affiliates.

Related